Tenderwize
Wróć do wyszukiwania

Eltrombopag rebate agreement

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Aug 03, 2027 · 340 days left·Open·Supplies·Framework
Zarejestruj się, aby zapisaćOpen documents
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Eltrombopag, ausgeschl. Anwendungsgebiet schwere aplastische Anämie in der Fachinformation, es sei denn, der Hersteller genießt hierfür Patenschutz, ATC B02BX05

46/100

Ocena szansy

Needs reviewMedium complexity
SuppliesFrameworkOpen
Skąd ta ocena?

Szansa

46 / 100

Złożoność

58 / 100

Czynniki ryzyka

The notice explicitly says the contract documents must be submitted via the communication area of the DTVP portal and n...

The final contract-conclusion deadline is 03.08.2027, and monthly cut-offs apply for next-month starts; missing the cut...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Sep 2027
  • Non-exclusive open-house rebate agreements for the medicinal product Eltrombopag (ATC B02BX05).
  • Exclusion of the severe aplastic anemia indication in the product information, unless the manufacturer has patent protection for that indication.
Pokaż pełne podsumowanie

Open-house supply arrangement for pharmaceutical products: non-exclusive rebate agreements for Eltrombopag (ATC B02BX05), excluding the severe aplastic anemia indication unless the manufacturer has patent protection for that indication. The contracting buyer is AOK Bayern. This is explicitly described as a non-competitive open-house model with no selection of one or more bidders; any pharmaceutical company meeting the stated suitability requirement may join on identical, non-negotiable terms. Contracting is possible until 03.08.2027, with monthly start dates depending on when complete documents are received. Procurement documents are available via DTVP, but only the notice text was analyzed, not the full document set.

Ryzyka

The notice explicitly says the contract documents must be submitted via the communication area of the DTVP portal and n...

The final contract-conclusion deadline is 03.08.2027, and monthly cut-offs apply for next-month starts; missing the cut...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • The contract and the annex 'Festlegung der vertragsgegenständlichen Arzneimittel' must be completed and signed.

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • A signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit) must be submitted.

Zamawiający

Lokalizacja

München, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE811695320

Działalność

Health

Części (1)

LOT-0001

Eltrombopag rebate agreement

Open-house rebate agreement for Eltrombopag, excluding the severe aplastic anemia indication in the product information unless the manufacturer has patent protection for that indication. Scope is supplies of pharmaceutical products under a non-exclusive, identical, non-negotiable rebate contract. The lot information comes from structured data and notice text.

SuppliesFrameworkEU fundedElectronic submission

Lokalizacja

DE212, Germany

Czas trwania

Sep 2025 - Sep 2027

Kategoria

Pharmaceutical products

Termin

Deadline Aug 03, 2027

Szczegóły zamówienia

Data publikacji
13 Aug 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
533121-2025

Dokumenty (2)

Dokument zamówienia 1Portal składania ofert 1

Podobne przetargi

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30